## **Core Concept**
The question tests the understanding of the mechanism of action of a specific class of drugs used to lower cholesterol levels. **HMG CoA reductase** is a key enzyme in the biosynthesis of cholesterol in the liver. Inhibiting this enzyme reduces cholesterol production.

## **Why the Correct Answer is Right**
The correct answer, **. Atorvastatin**, acts by inhibiting **HMG CoA reductase**, which is a crucial enzyme in the hepatic production of cholesterol. By inhibiting this enzyme, atorvastatin decreases the liver's ability to produce cholesterol, leading to a decrease in circulating cholesterol levels. Atorvastatin is a member of the **statin** class of drugs, which are well-known for their effectiveness in lowering low-density lipoprotein (LDL) cholesterol.

## **Why Each Wrong Option is Incorrect**
* **Option A:** is incorrect because it does not represent a drug known for inhibiting HMG CoA reductase.
* **Option B:** is incorrect because, although it might represent another drug, it does not act by inhibiting HMG CoA reductase.
* **Option D:** is incorrect because it also does not act through the inhibition of HMG CoA reductase.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **statins**, like atorvastatin, are the first-line treatment for hypercholesterolemia and work by inhibiting **HMG CoA reductase**. A classic clinical correlation is that statins can cause **myopathy** as a side effect, which is a significant consideration in patients taking these drugs.

## **Correct Answer:** . Atorvastatin